Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
545 participants
INTERVENTIONAL
2013-01-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Staff from the hospital ward identifies patients fulfilling the inclusion criteria and refers the patients to two project nurses at the hospital (follow home team). One of the project nurses gets the informed consent from the patient, or in case of a patient who is not able to give informed consent, from the family and general practitioner. The patient is then randomized to intervention (follow home visit after discharge) or control.
In the intervention group, the hospital project nurse and the patient meets with the municipal nurse in the patient's home on the same day the patient is being discharged from the hospital. During this visit the discharge from the hospital and the actual functioning of the patient in his own surroundings is reviewed, using a structured assessment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Municipality-based Post-discharge Follow-up Visits
NCT02094040
Early Geriatric Follow-up in Older Acute Medical Patients
NCT02664948
Interventional Study of Videoconferences Between Hospital and Municipality - a Randomized Controlled Trial
NCT02303249
Effect of a Transitional Care Intervention
NCT04796701
Extended Cross-sectoral Nurse Follow-up After Discharge From a Geriatric Ward - Benefits and Challenges. A Mixed-method Study
NCT05139823
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Cognitive skills
* Medicine
* Nutrition
* Mobility
* Level of functioning
* Future appointments in the health care sector
All patients in the project - both patients in the intervention group and patients in the control group - will receive treatment and care equivalent to normal applicable quality standards with discharge from the hospital.
It is expected that the study will demonstrate a reduction of hospital readmissions within 180 days in the intervention group with 14 % (with a power of 90% and a significance level of 5%). There will be a need for 200 patients in both the control and intervention group, ie 400 patients in total.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Review of follow home visits after discharge from Nykøbing Falster Hospital
Review of follow home visits after discharge from Nykøbing Falster Hospital
The intervention is follow home visits which is randomized and is an intervention that is assigned by the investigator.
Control
Standard health care and discharge services
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Review of follow home visits after discharge from Nykøbing Falster Hospital
The intervention is follow home visits which is randomized and is an intervention that is assigned by the investigator.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Address in Guldborgsund, Lolland or Vordingborg municipalities.
Minimum 3 out of the following 9 criteria must be met:
* The patient's behavior raises suspicion of cognitive disorders, including dementia, which affects how the patient masters his daily life.
* The patient has an abuse of medication, drugs and / or alcohol, which affects how the patient masters his daily life.
* The patient has a psychiatric disorder that affects how the patient masters his daily life.
* The patient has a strained - or no - social network.
* The patient has a significantly lower level of functioning compared to prior to admission.
* The patient uses 6 or more different types of drugs at the time of discharge.
* The patient has, within the preceding 6 months, had at least one acute hospital contact beyond the current.
* The patient has a fall-history where the cause is not yet determined.
* There are suspicion of housing conditions that hamper the patient in his daily activities.
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Zealand
OTHER
Nykøbing Falster County Hospital
OTHER
Guldborgsund Municipality
UNKNOWN
Lolland Municipality
UNKNOWN
Vordingborg Municipality
UNKNOWN
Zealand University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maurice Antoine Lembeck, MD
Role: STUDY_DIRECTOR
Region Zealand, Nykøbing Falster Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Region Zealand, Nykøbing Falster Hospital
Nykøbing Falster, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lembeck MA, Thygesen LC, Sorensen BD, Rasmussen LL, Holm EA. Effect of single follow-up home visit on readmission in a group of frail elderly patients - a Danish randomized clinical trial. BMC Health Serv Res. 2019 Oct 25;19(1):751. doi: 10.1186/s12913-019-4528-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SJ-329
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.